Turn to the nation's most objective and informative daily environmental news resource to learn how the United States and key players around the world are responding to the environmental...
Environmental groups are challenging an Environmental Protection Agency decision to allow the sale of an herbicide marketed as a solution for farmers dealing with difficult weeds ( Nat’l Family Farm Coal. v. EPA , 9th Cir., No. 17-70196, 1/20/17 ).
The challengers, which include the National Family Farm Coalition, Center for Food Safety, Center for Biological Diversity and Pesticide Action Network North America, filed a lawsuit Jan. 20 in the Ninth U.S. Circuit Court of Appeals against the EPA’s approval of Monsanto Co.'s XtendiMax, a combination of the herbicides dicamba and glyphosate.
In a statement, the groups cited health concerns due to increased pesticide exposure and the evolution of more herbicide-resistant weeds as reasons to rescind the approval.
“Federal regulators have abandoned the interests of farmers, the environment and public health,” said George Kimbrell, an attorney with the Center for Food Safety. “We won’t allow our food to be dragged backward into a pesticide-soaked nightmare—not without a hell of a fight.”
The petition for review stated that the EPA violated the Federal Insecticide, Fungicide and Rodenticide Act in issuing a conditional registration for the herbicide, which allows Monsanto to legally sell the product through Nov. 9, 2018. The groups also charge the EPA with failing to consult with the U.S. Fish and Wildlife Service and National Marine Fisheries Service on whether the weedkiller harms plants and animals listed under the Endangered Species Act.
In a statement, the challengers cited a 2001 study that linked dicamba and other pesticides with an elevated risk of non-Hodgkins lymphoma. Glyphosate also was identified as a “probable” carcinogen in 2015 by the World Health Organization’s International Agency for Research on Cancer, a finding that Monsanto and the pesticide industry have sharply refuted.
The EPA approved the weedkiller Nov. 9, 2016. It is designed to be used on Monsanto’s cotton and soybean plants that are genetically engineered to withstand the herbicide.
XtendiMax is formulated to be less prone to drifting in the wind than older versions of dicamba. The delay in approving the herbicide led to farmers using older, high-volatility versions of dicamba last summer on genetically engineered soybeans, leading to a record number of complaints from farmers whose crops were damaged.
Last year, an Arkansas farmer was shot and killed over a dispute over soybean damage from drifting dicamba.
In its approval of XtendiMax, the EPA also imposed restrictions on how it can be used. Spraying the herbicide from aircraft is not allowed and growers cannot use the weedkiller when wind speeds are above 15 miles an hour.
The proliferation of weeds resistant to glyphosate, the world’s most common herbicide, has created demand for alternatives. Monsanto is investing nearly $1 billion in its Luling, La., dicamba plant through 2019.
A Monsanto spokeswoman told Bloomberg BNA in a statement that the EPA’s approval follows more than seven years of scientific review. “Dicamba-based herbicides have a 40-year history of safe use, and we are confident the Government’s exhaustive assessment will prevail,” said Charla Lord.
To contact the reporter on this story: Tiffany Stecker in Washington, D.C., at email@example.com
To contact the editor responsible for this story: Larry Pearl at firstname.lastname@example.org
The petition to review the Environmental Protection Agency's approval of XtendiMax is available at http://src.bna.com/lBd.
Copyright © 2017 The Bureau of National Affairs, Inc. All Rights Reserved.
All Bloomberg BNA treatises are available on standing order, which ensures you will always receive the most current edition of the book or supplement of the title you have ordered from Bloomberg BNA’s book division. As soon as a new supplement or edition is published (usually annually) for a title you’ve previously purchased and requested to be placed on standing order, we’ll ship it to you to review for 30 days without any obligation. During this period, you can either (a) honor the invoice and receive a 5% discount (in addition to any other discounts you may qualify for) off the then-current price of the update, plus shipping and handling or (b) return the book(s), in which case, your invoice will be cancelled upon receipt of the book(s). Call us for a prepaid UPS label for your return. It’s as simple and easy as that. Most importantly, standing orders mean you will never have to worry about the timeliness of the information you’re relying on. And, you may discontinue standing orders at any time by contacting us at 1.800.960.1220 or by sending an email to email@example.com.
Put me on standing order at a 5% discount off list price of all future updates, in addition to any other discounts I may quality for. (Returnable within 30 days.)
Notify me when updates are available (No standing order will be created).
This Bloomberg BNA report is available on standing order, which ensures you will all receive the latest edition. This report is updated annually and we will send you the latest edition once it has been published. By signing up for standing order you will never have to worry about the timeliness of the information you need. And, you may discontinue standing orders at any time by contacting us at 1.800.372.1033, option 5, or by sending us an email to firstname.lastname@example.org.
Put me on standing order
Notify me when new releases are available (no standing order will be created)